R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-01.jpg (Allopurinol 01)
Allopurinol
Product Images NDC 53002-4820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53002-4820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-02.jpg (Allopurinol 02)
Allopurinol is a medication that blocks the production of uric acid in the body. It is converted into a compound called oxipurinol. The chemical formula of allopurinol is dibydro-4Hpyrazolo-H-pyrazalo (3,4-0) yrimidin-d-one, while oxipurinol can be represented as pyrimidine, 4.6 (SH,7H)-dione. Allopurinol works by inhibiting the enzyme xanthine oxidase, which is responsible for the conversion of hypoxanthine to xanthine and ultimately to uric acid. By reducing the amount of uric acid in the body, allopurinol helps to prevent gout and kidney stones.*
Label Image (Lbl530024820)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
